Document is current
Any future updates will be listed below
-
Authors
Goto, Keisuke
Osaki, Mitsuhiko
Izutsu, Runa
Tanaka, Hiroshi
Sasaki, Ryo
Tanio, Akimitsu
Satofuka, Hiroyuki
Kazuki, Yasuhiro
Yamamoto, Manabu
Kugoh, Hiroyuki
Ito, Hisao
Oshimura, Mitsuo
Fujiwara, Yoshiyuki
Okada, Futoshi
-
Funding
Funding for this research was provided by:
The Japanese Ministry of Education, Culture, Sports, Science and Technology (20K07447, 20K16303)
CREST from Japan Science and Technology Agency (JPMJCR18S4)
Basis for Supporting Innovative Drug Discovery and Life Science Research of Japan Agency for Medical Research and Development (JP21am0101124)
- License Information
-
More Information
Article History
Received: 24 September 2021
Accepted: 26 November 2021
First Online: 30 January 2022
Declarations
:
: The experimental protocol was conducted according to the guidelines of the Declaration of Helsinki, approved by the Tottori University Hospital Institutional Review Board (ID: 17A142 on June 26, 2018), and approved by the Committee of the Institute for Animal Experimentation of Tottori University (ID: 17-Y-28 on September 11, 2017).
: Not applicable.
: MOsh is a CEO, employee and shareholder of Trans Chromosomics, Inc. HT is employees of Trans Chromosomics, Inc. The other authors declare no financial or other interests regarding this manuscript that might be construed as a conflict of interest
